Deal & Dollar Raised for U.S.

Venture-Backed Companies (2003- 3Q' 2009)

*Equity financings include cash investments by professional venture capital firms, corporations, other private equity firms, and individuals into

Number of Financing Rounds

2008 2009
Industry Group 1Q 2Q 3Q 4Q Total 1Q 2Q
Business and Financial Services 99 96 91 76 362 75 70
Consumer Goods 10 15 15 14 54 10 14
Consumer Services 31 32 24 19 106 25 24
Energy and Utilities 28 37 34 37 136 17 27
Health Care 178 184 166 160 688 128 178
Industrial Goods and Materials 16 22 25 14 77 10 21
Information Technology 384 346 305 293 1328 229 248
Other 4 5 3 6 18 3 13
Grand Total 750 737 663 619 2769 497 595

Amount Invested ($M)

2008 2009
Industry Group 1Q 2Q 3Q 4Q Total 1Q 2Q
Business and Financial Services $1,106.98 $905.68 $821.08 $440.29 $3,274.03 $526.65 $562.33
Consumer Goods $210.95 $238.94 $202.43 $59.10 $711.42 $144.48 $180.25
Consumer Services $451.77 $240.35 $191.59 $383.32 $1,267.03 $120.69 $86.79
Energy and Utilities $637.85 $1,071.99 $1,356.40 $879.03 $3,945.27 $219.35 $310.24
Health Care $2,254.89 $2,576.01 $2,293.38 $1,822.63 $8,946.91 $1,393.17 $2,210.60
Industrial Goods and Materials $235.83 $174.42 $230.89 $112.07 $753.21 $31.91 $91.87
Information Technology $3,650.34 $3,130.78 $3,070.37 $2,377.81 $12,229.30 $1,631.55 $1,940.15
Other $10.00 $8.95 $4.30 $12.10 $35.35 $14.00 $37.70
Grand Total $8,558.61 $8,347.11 $8,170.44 $6,086.34 $31,162.50 $4,081.80 $5,419.92

Median Deal Size ($M)

1Q08 2Q08 3Q08 4Q08 Y2008 1Q09 2Q09
Grand Total $6.80 $7.50 $7.00 $6.00 $7.00 $5.10 $5.00

Largest U.S. Deals Overall in 3Q' 2009

Company Name City State IndustryCode IndustrySegment

IndustryGroupCloseDate RoundType
WastePro USA Inc. Longwood FL EnvironmentalOther
Services
BusinessBusiness
and Financial
and Financial
Services
09/25/09
Services
Later
Facebook Palo Alto CA Online Communities
Information Services
Information Technology
07/13/09 Corp
Tesla Motors Inc. San Carlos CA Automobiles Vehicles and Parts
Consumer Goods 08/31/09 6th
Pacific Biosciences of California Menlo Park CA BiotechnologyBiopharmaceuticals
Therapeutics Healthcare 07/31/09 6th
Complete Genomics Mountain ViewCA Drug Development
Biopharmaceuticals
Technologies
Healthcare 08/24/09 4th
Oraya Therapeutics Newark CA Therapeutic Devices
Medical(Minimally
Devices/Equipment
Healthcare
and Non-Invasive)
07/20/09 3rd
Direct Flow Medical Inc. Santa Rosa CA Therapeutic Devices
Medical(Invasive)
Devices/Equipment
Healthcare 09/18/09 3rd
Adamas Pharmaceuticals Emeryville CA Pharmaceuticals
Biopharmaceuticals
Healthcare 08/18/09 3rd
Epizyme Inc. Cambridge MA BiotechnologyBiopharmaceuticals
Therapeutics Healthcare 09/30/09 2nd
equity firms, and individuals into companies that have received at least one round of venture funding.

2009
3Q 4Q Total
81 226
14 38
20 69
23 67
184 490
17 48
270 747
7 23
616 1708

2009
3Q 4Q Total
$559.86 $1,648.84
$206.84 $531.57
$125.10 $332.58
$415.47 $945.06
$1,720.90 $5,324.67
$169.06 $292.84
$1,867.75 $5,439.44
$21.37 $73.07
$5,086.34 $14,588.06

3Q09 YTD2009
$5.00 $5.00

RoundClass RoundBusinessStatus
RaisedUSD Investors BriefDescription
Later Profitable $100.00 Roark Capital Provider
Group of waste collection service.
Corporate Profitable $100.00 Provider of an online social directory designed to help people communicate with their friends, family,
6th Shipping Product $82.50 Daimler AG, Fjord
Developer
Ventures
of energy-efficient electric sports cars.
6th Product Development$68.00 AllianceBernstein,
Developer
Alloy Ventures,
of a transformative
Blackstonesingle-molecule,
Group, Duff Ackerman
real-time& (SMRT)
Goodrich,
DNAIntel
sequencing
Capital, Kleiner
platform.
Perkins Cau
4th Product Development$45.00 Enterprise Partners
Developer
Venture
of DNA
Capital,
sequencing
Essex Woodlands
methods. Health Ventures, Highland Capital Management, OrbiMed
3rd Product Development$42.00 Domain Associates*,
Developer
Essex
of radiosurgical
Woodlands Health
treatments
Ventures,
for eye
Scale
diseases.
Venture Partners*, Synergy Life Science Partners
3rd Clinical Trials - Generic
$40.00 EDF Ventures,Developer
ePlanet Ventures,
of medicalFoundation
devices forMedical
interventional
Partners, cardiology.
New Leaf Venture Partners, Spray Venture Partne
3rd Product Development$40.00 Aeris Capital*,Developer
Duff Ackerman
of neuroprotective
& Goodrich*, Mohr
medicines
Davidow
for the
Ventures,
treatmentNorthgate
of central
Capital
nervousGroup
system (CNS) disorders
Second RoundProduct Development$32.00 Amgen Ventures, Developer
AstellasofVenture
epigenetic
Capital,
enzymes
Bay City
solutions
Capital*,
to treat
Kleiner
illness.
Perkins Caufield & Byers, MPM Capital
eople communicate with their friends, family, and coworkers.

e (SMRT) DNA sequencing platform.

nt of central nervous system (CNS) disorders.